Cart
sales@molnova.com
Arg-Gly-Asp TFA
CAS No. ——
Arg-Gly-Asp TFA ( —— )
Catalog No. M19317 CAS No. ——
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 58 | Get Quote |
|
| 10MG | 100 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameArg-Gly-Asp TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionRGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
-
DescriptionRGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetATM/ATR
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight460.36
-
Molecular FormulaC14H23F3N6O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N.FC(F)(F)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hersel U, et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003 Nov;24(24):4385-415.
molnova catalog
related products
-
Chloroquine diphosph...
Chloroquine diphosphate is used as an antimalarial drug and also functions to increase sensitivity of tumor cells to radiation and chemotherapy via inducing autophagy .
-
GJ103 sodium salt
A novel small molecular read-through (SMRT) compound that can induce read through of nonsense mutations in the ATM gene.
-
Camonsertib
Camonsertib (RP-3500) is a novel, potent and selective ATR kinase inhibitor (ATRi) that exhibits potent antitumor effects with an IC50: 1.00 nM in biochemical assays.
